Prenexus Health is a leading player in the prebiotics industry, dedicated to revolutionizing digestive and microbiome health through scientific and clinical research. Established in 2015, the company specializes in manufacturing branded prebiotic components for a wide range of products including vitamins, dietary supplements, food, and beverages. With a strong emphasis on rigorous research and development, Prenexus Health has solidified its position as a global leader in the field of prebiotics. The latest milestone for the company was the Series A investment in April 2020, which garnered support from a consortium of notable investors including ADM Capital, Cibus Capital, DSM Venturing, Once Ventures, PeakBridge Ventures, Coalescence Partners, and Continental Grain Company. This backing not only reflects confidence in the company's vision but also provides a strong financial foundation for Prenexus Health to further its groundbreaking work in the realm of digestive and microbiome health.
No recent news or press coverage available for Prenexus Health.